Trends in biomaterials for three dimensional cancer modeling
During the last decade, the type of biological assays that are used for extracting information about the efficiency of drugs (including cancer-related compounds) have dramatically changed. The reason is that a large amount of these drugs fail when they are tested in preclinical assays. This is becau...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | bookPart |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/1822/77881 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/77881 |